|
UBS AG Lowers LipoScience Price Target to $6.50 (LPDX) - Zolmax
<img alt="" height="1" width="1" /> UBS AG Lowers LipoScience Price Target to $6.50 (LPDX) Zolmax The Company's first diagnostic test, the nuclear magnetic resonance (NASDAQ:LPDX) LipoProfile test, directly measures the number of low density lipoprotein (LDL), particles in a blood sample and provides physicians and their patients with actionable ... UBS AG Lowers LipoScience Price Target to $6.50 (LPDX) - Zolmax More... |
| All times are GMT. The time now is 04:52 AM. |
Powered by vBulletin® Version 3.7.3
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.
Search Engine Friendly URLs by vBSEO 3.6.0
Copyright, BioNMR.com, 2003-2013